Clinical Trials Logo
  1. Home
  2. Cancer
  3. NCT04932681
  4. Details
NCT04932681 Clinical Trial

Use of Medicinal Plants and Other Alternative and Complementary Medicines by Patients With Cancer in Reunion Island

Cancer Clinical Trial

— CAMUCRI  

Official title:
Evaluation of the Use of Medicinal Plants and Other Alternative and Complementary Medicines by Patients With Cancer in Reunion Island

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT04932681
Other study ID # 2021/CHU/05
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date April 2022
Est. completion date December 2023

Study information
Verified date March 2022
Source Centre Hospitalier Universitaire de la Réunion
Contact Florent DRAPEAU, PharmD
Phone 02 62 35 90 00
Email florent.drapeau@chu-reunion.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Exploratory, observational and cross-sectional study with the aim of describing the use of plants for medicinal purposes (and other Complementary and Alternative Medicine) and identifying the determinants of this use. The methodology envisaged is mixed with an exploratory design combining qualitative (interviews) and quantitative techniques (questionnaires). To knowledge of investigators, no study has been carried out in Reunion Island on the use of plants and other alternative and complementary medicines among cancer patients.

Recruitment information / eligibility
Status Recruiting
Enrollment 520
Est. completion date December 2023
Est. primary completion date April 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Living in Reunion Island - Suffering from cancer (solid tumors, hematological malignancies) - Able to answer a questionnaire - Patient who does not oppose to the research Exclusion Criteria: - Person of legal age under guardianship or under legal protection - Persons who do not understand French or Reunionese Creole

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
Réunion CHU La Réunion Saint-Denis
Réunion Clinique Saint Clotilde Sainte-Clotilde

Sponsors (2)
Lead Sponsor Collaborator
Centre Hospitalier Universitaire de la Réunion APLAMEDOM

Country where clinical trial is conducted

Réunion, 

Outcome
Type Measure Description Time frame Safety issue
Primary Use of herbal medicine Proportion of patients using herbal medicine (from the patient's perspective) among cancer patients. Day 1
Secondary Barriers of dialogue between patient and practionner Interviews between patient and interviewer will help to extract the barriers limiting patient/practitioner dialogue on Complementary and Alternative Medicine use from patient and practitioner perspectives Day 1
Secondary Need for Information on Complementary and Alternative Medicine Interviews between patient and interviewer will help to find out expectations about the need for information on Complementary and Alternative Medicine use from the patient's perspective and from the practitioner's perspective Day 1
Secondary Improving questionnaire after the practionners' focus group A practionners' focus group will be organised after the interviews to review the feedbacks and opinions on the questionnaire to improve the questionnaire for the quantitative part of the study Day 1
See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT04448041 - CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients